Insider Transactions in Q1 2021 at Iterum Therapeutics PLC (ITRM)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2021
|
Alexander J Denner > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,619,949
-100.0%
|
$21,239,898
$2.27 P/Share
|
|
Feb 11
2021
|
Alexander J Denner > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,000,000
-48.5%
|
$20,000,000
$2.59 P/Share
|
|
Feb 11
2021
|
Alexander J Denner > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
20,619,949
+50.0%
|
-
|
|
Feb 04
2021
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
11,651,597
+50.0%
|
-
|
|
Jan 26
2021
|
Judith M. Matthews Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
33,868
-54.19%
|
$33,868
$1.73 P/Share
|
|
Jan 26
2021
|
Michael W. Dunne |
SELL
Open market or private sale
|
Direct |
33,143
-11.45%
|
$33,143
$1.73 P/Share
|
|
Jan 26
2021
|
Corey N. Fishman Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
85,445
-20.97%
|
$85,445
$1.73 P/Share
|
|
Jan 25
2021
|
Judith M. Matthews Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+50.0%
|
-
|
|
Jan 25
2021
|
Michael W. Dunne |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+21.65%
|
-
|
|
Jan 25
2021
|
Corey N. Fishman Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
167,500
+29.13%
|
-
|